Quick Takeaways
- APPLIED GENETIC TECHNOLOGIES CORP has 15 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are not currently available.
- Info
- Insider Trading
- Financials
Insider Transactions Reported by 15 Insiders of APPLIED GENETIC TECHNOLOGIES CORP
- Location
- Alachua, FL
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 24 Apr 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
APPLIED GENETIC TECHNOLOGIES CORP executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| William Aliski | Director | Mixed | 30 Nov 2022 | |||
| Scott Koenig | Director | Mixed | 30 Nov 2022 | |||
| Gerald Anthony Reynolds | Chief Accounting Officer | Mixed | 30 Nov 2022 | |||
| Stephen W. Potter | Chief Business Officer | Mixed | 30 Nov 2022 | |||
| Susan B. Washer | President and CEO, Director | Mixed | 30 Nov 2022 | |||
| Jonathan I. Lieber | Chief Financial Officer | Mixed | 30 Nov 2022 | |||
| Abraham Scaria | Chief Scientific Officer | Mixed | 30 Nov 2022 | |||
| Hope DOyley-Gay | General Counsel | Mixed | 30 Nov 2022 | |||
| Anne Vanlent | Director | Mixed | 30 Nov 2022 | |||
| Yehia Hashad | Director | Mixed | 30 Nov 2022 | |||
| Susan Schneider | Chief Medical Officer | Mixed | 30 Nov 2022 | |||
| James A. Robinson Jr. | Director | Mixed | 30 Nov 2022 | |||
| Edward Hurwitz | Director | Mixed | 30 Nov 2022 | |||
| Ivana Magovcevic-Liebisch | Director | Mixed | 30 Nov 2021 | |||
| James Rosen | Director | Mixed | 30 Nov 2022 |
Top shareholders of APPLIED GENETIC TECHNOLOGIES CORP (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Ivana Magovcevic-Liebisch |
3/4/5
|
Director |
—
class O/S missing
|
14,000
|
— | — | 30 Nov 2021 |
Recent Insider Transactions by Companies or Individuals for APPLIED GENETIC TECHNOLOGIES CORP
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* An asterisk sign (*) next to the price indicates that the price is likely invalid.